N
This startup develops precision diagnosis software that predicts molecular pathology values from MRI images. The software analyzes MRI scans to assess the effects and side effects of specific treatment drugs, enabling healthcare providers to determine drug suitability for patients with degenerative brain diseases.
Updated 18 months ago
Funding
Funding not disclosed
DPFunding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This startup develops precision diagnosis software that predicts molecular pathology values from MRI images. The software analyzes MRI scans to assess the effects and side effects of specific treatment drugs, enabling healthcare providers to determine drug suitability for patients with degenerative brain diseases.